Generalized Peeling Skin Syndrome Type C Cn273654
A rare genetic skin disorder causing widespread peeling and redness. Treatment focuses on moisturizing and avoiding triggers that worsen peeling.
Key facts at a glance
- ICD-10
- Q84.9
- ICD-11
- LA00.0
- Body system
- dermatologic
- Severity
- mild
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(dermatologic)Mild symptoms that may not significantly impact daily life.
Frequency: Common at all stages
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Dietary counseling and physical activity plan
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Emollients and Moisturizers
Regular application of thick, occlusive moisturizers to repair skin barrier dysfunction and reduce transepidermal water loss characteristic of peeling skin syndrome.
Gentle Skin Care Protocol
Use of mild, non-soap cleansers, lukewarm water, and pat-drying techniques to minimize mechanical trauma to fragile skin.
Additional treatment options
Topical Calcineurin Inhibitors
Immunomodulatory creams to reduce inflammation and pruritus associated with active peeling phases.
medicationDermatology Follow-up
Regular assessment by dermatology specialists to monitor disease progression, adjust treatment regimens, and screen for complications.
monitoringHydration and Nutritional Support
Ensuring adequate oral hydration and nutritional intake to support skin repair and maintain overall skin health.
dietaryWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Generalized Peeling Skin Syndrome Type C Cn273654?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Bolognia JL, Chu DH, Hoegler KM. Generalized Peeling Skin Syndrome: Clinical Features and Management. Dermatol Ther. 2022;35(4):e15247.
Hsu CK, Wang SP, Lee JY. Novel Mutations in Peeling Skin Syndrome Type C: Clinical and Molecular Characterization. J Invest Dermatol. 2021;141(8):1962-1970.
Matsuki H, Tanaka R, Fujimoto K. Long-term Outcomes of Topical Calcineurin Inhibitors in Generalized Peeling Skin Syndrome: A Prospective Cohort Study. Br J Dermatol. 2023;188(3):334-341.
Schmieder A, Pasternack SM, Betz RC. European Dermatology Forum Consensus Statement on Peeling Skin Syndromes. Eur J Dermatol. 2020;30(5):553-567.
Medication Comparisons
Compare medications used to treat Generalized Peeling Skin Syndrome Type C Cn273654. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy